Medpace Holdings, Inc. (MEDP)

Services-Commercial Physical & Biological Research · Technology · $8.7B

overvalued
Intrinsic Value (Consensus)
$226.98
Current Price
$305.60
Margin of Safety
-25.7%
25.7% Above Intrinsic Value
Value: $227
Price: $306

Valuation Model Estimates

Current Price: $305.60
DCF (Discounted Cash Flow)
$1119.62
Graham Number
$74.34
Earnings Power Value
$148.35
Relative Value (P/E)
$305.60
Dividend Discount Model
Not applicable
Consensus Value
$226.98

Model Assumptions

Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%

Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.

Key Financials

EPS (TTM)
$15.28
EPS (Forward)
$18.34
Book Value
$16.07
P/E Ratio
20.0
Forward P/E
16.7
PEG Ratio
ROE
98.3%
Debt/Equity
36%
Revenue Growth
20.0%
Earnings Growth
20.0%
Dividend Yield
N/A
Beta
1.00

Data last updated: 2026-06-12

Source: Yahoo Finance